TY - JOUR
T1 - Intravenous igg to prevent graft-versus-host disease after bone marrow transplantation
AU - Bailey, Thomas C.
AU - Wingard, John R.
AU - Vogelsang, Georgia
AU - Piantadosi, Steven
AU - Sullivan, Keith M.
AU - Kopecky, Kenneth J.
AU - Buckner, C. Dean
AU - Storb, Rainer
PY - 1991/2/28
Y1 - 1991/2/28
N2 - Sullivan et al. (Sept. 13 issue)1 report that the administration of intravenous immunoglobulin to patients undergoing bone marrow transplantation had beneficial effects with respect to the amelioration of graft-versus-host disease, interstitial pneumonitis, and infections. However, caution is warranted in the light of the cost of the immunoglobulin regimen described. Hospital pharmacies typically charge patients a fixed percentage above the “average wholesale price” of a given pharmaceutical agent, although the average wholesale price does not necessarily reflect the acquisition cost of the drug. The average wholesale price for the drug used in the study, Gamimune N, is 285.60 …
AB - Sullivan et al. (Sept. 13 issue)1 report that the administration of intravenous immunoglobulin to patients undergoing bone marrow transplantation had beneficial effects with respect to the amelioration of graft-versus-host disease, interstitial pneumonitis, and infections. However, caution is warranted in the light of the cost of the immunoglobulin regimen described. Hospital pharmacies typically charge patients a fixed percentage above the “average wholesale price” of a given pharmaceutical agent, although the average wholesale price does not necessarily reflect the acquisition cost of the drug. The average wholesale price for the drug used in the study, Gamimune N, is 285.60 …
UR - http://www.scopus.com/inward/record.url?scp=0026084903&partnerID=8YFLogxK
U2 - 10.1056/NEJM199102283240912
DO - 10.1056/NEJM199102283240912
M3 - Letter
C2 - 1992325
AN - SCOPUS:0026084903
SN - 0028-4793
VL - 324
SP - 631
EP - 633
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 9
ER -